Boston Scientific Corporation (BSX) Income Statement

	FY25	FY24	FY23	FY22	FY21	FY20	YoY
Revenue
Total Income / Revenue	$20.1B	$16.7B	$14.2B	$12.7B	$11.9B	$9.9B	+19.9%
Cost of Sales	$6.2B	$5.3B	$4.3B	$4.0B	$3.7B	$3.5B	+18.3%
Gross Profit	$13.9B	$11.5B	$9.9B	$8.7B	$8.2B	$6.4B	+20.6%
Expenses
Operating Expenses	$10.2B	$8.9B	$7.6B	$7.1B	$7.0B	$6.5B	+15.2%
Depreciation & Amortisation	$1.4B	$1.3B	$1.2B	$1.1B	$1.1B	$1.1B	+7.8%
Profit
Operating Profit	$3.6B	$2.6B	$2.3B	$1.6B	$1.2B	-$80.0M	+38.8%
Profit Before Tax	$3.4B	$2.3B	$2.0B	$1.1B	$1.1B	-$79.0M	+48.3%
Tax Expense	$493.0M	$436.0M	$393.0M	$443.0M	$36.0M	$2.0M	+13.1%
Profit After Tax	$2.9B	$1.8B	$1.6B	$698.0M	$1.0B	-$82.0M	+56.7%
Minority Interests	-$6.0M	-$8.0M	-$1.0M	$0	$0	—	+25.0%
Total Comprehensive Income	$2.0B	$2.1B	$1.4B	$704.0M	$1.1B	-$145.0M	-2.1%
Basic EPS	$1.96	$1.26	$1.08	45.00¢	69.00¢	-8.00¢	+55.6%
Diluted EPS	$1.94	$1.25	$1.07	45.00¢	69.00¢	-8.00¢	+55.2%

New to Ticker

Create a free Ticker account to see every line of the income statement, balance sheet and cash flow, plus dividends and financial health.

Boston Scientific Corporation — Income Statement